In today’s therapeutic reality where a large percentage of menopausal women as well as their health care providers are searching for a viable solution, Femarelle^® creates an exceptional business opportunity.

Se-cure' strategic goal is to turn Femarelle^® into the leading product for the management of menopause favored by the medical community as well as the consumer. In order to achieve this feat we are looking to market Femarelle^® through leading pharmaceutical companies as an "ethical" product through detailing of healthcare practitioners with the added advantage of being able to target the consumer as a second step.

Se-cure’s unique technology in manufacturing stable biochemical compounds and its innovative pipeline create an opportunity for joint research partnerships with pharmaceutical companies, researchers and the academia.

To partner with us, please contact a representative in one of the following areas: